CCT301-38 CAR-T in Patients With Relapsed or Refractory AXL Positive Sarcomas
Clinical trial NCT05128786 · TERMINATED
Trial details
- NCT number
- NCT05128786
- Sponsor
- Shanghai PerHum Therapeutics Co., Ltd.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-30
- Primary completion
- 2024-08-15
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.